What alternative medication can be used for postural orthostatic tachycardia syndrome (POTS) instead of metoprolol?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Alternative Medications to Metoprolol for POTS

Midodrine (2.5-15 mg every 4 hours up to 3 times per day) is the strongest recommended alternative to metoprolol for POTS, with a Strong Recommendation based on Moderate-Quality Evidence. 1

Primary Pharmacologic Alternatives

First-Line Alternative: Midodrine

Midodrine is the most robustly recommended medication for POTS symptom control according to the 2020 Canadian Cardiovascular Society guidelines 11. This alpha-agonist works by enhancing vasoconstriction and improving central blood volume, making it particularly effective in patients with:

  • Tendency toward hypotension or low blood pressure phenotype
  • Symptoms related to venous pooling
  • Inadequate vasoconstriction during orthostatic stress

Important caveat: Midodrine may be less beneficial in hyperadrenergic POTS patients who already have elevated blood pressure or hypertensive tendencies 1.

Alternative Beta-Blocker: Propranolol

If you're specifically looking to replace metoprolol with another beta-blocker, low-dose propranolol (10-20 mg four times per day) is recommended over metoprolol 11. The guidelines emphasize:

  • Use nonselective beta-blockers (propranolol) rather than selective ones (metoprolol)
  • Keep doses low (10-20 mg QID)
  • Higher doses and long-acting formulations are generally ineffective for symptom control
  • Side effects include worsening exercise tolerance and fatigue, which can interfere with the critical exercise therapy component 1

Critical distinction: The guidelines specifically recommend propranolol as a nonselective beta-blocker with a Strong Recommendation, while metoprolol (a selective beta-blocker) is not the preferred agent 11.

Additional Pharmacologic Options

Ivabradine (2.5-7.5 mg twice daily)

This selective heart rate-lowering agent has a Weak Recommendation with Low-Quality Evidence 1. Recent systematic reviews show ivabradine effectively lowers heart rate and provides symptomatic relief without blood pressure reduction 23. It's particularly useful when:

  • Beta-blockers are poorly tolerated
  • Pure heart rate control is needed without blood pressure effects
  • Exercise intolerance from beta-blockers is problematic

Pyridostigmine

This acetylcholinesterase inhibitor can be helpful, especially when combined with a beta-blocker 11. Consider it for:

  • Patients with constipation (diarrhea is a common side effect that may be beneficial)
  • Combination therapy to reduce orthostatic tachycardia

Avoid in: Patients with frequent bowel movements or bladder dysfunction 1.

Fludrocortisone

Works through volume expansion and may be helpful when patients cannot optimize oral salt intake 11. Monitor for:

  • Edema and hypokalemia
  • Possible osteoporosis risk in young women
  • Exacerbation of migraines (avoid in migraine patients)
  • Regular electrolyte monitoring, especially potassium 1

Clonidine (0.1-0.2 mg up to 3 times daily)

For hyperadrenergic POTS with prominent sympathetic overactivity (Weak Recommendation, Low-Quality Evidence) 1. Useful for:

  • Palpitations and tremors
  • Significant orthostatic symptoms with hyperadrenergic features

Caution: May worsen symptoms in patients with supine hypotension or orthostatic hypotension; side effects include sedation and dry mouth 1.

Treatment Algorithm

Step 1: Ensure non-pharmacologic measures are optimized first:

  • Fluid intake ≥3 L daily
  • Salt intake 10 g daily
  • Compression garments (waist-high, 20-30 mmHg)
  • Exercise training (semi-recumbent initially, ≥4 days/week, ≥30 minutes) 1

Step 2: Choose pharmacologic therapy based on phenotype:

  • Low blood pressure phenotype → Midodrine first-line
  • High heart rate with hyperadrenergic features → Low-dose propranolol or clonidine
  • Neuropathic/vasoconstriction issues → Midodrine or pyridostigmine
  • Beta-blocker intolerance → Ivabradine

Step 3: Consider combination therapy if monotherapy inadequate:

  • Pyridostigmine + beta-blocker
  • Midodrine + low-dose propranolol (if blood pressure tolerates)

Common Pitfalls to Avoid

  1. Don't use high-dose or long-acting beta-blockers – they worsen exercise tolerance without improving symptoms 11
  2. Don't use selective beta-blockers like metoprolol as first choice – nonselective propranolol is preferred 1
  3. Avoid fludrocortisone in migraine patients – can exacerbate migraine frequency 1
  4. Don't use routine IV saline chronically – risk of infection and thrombosis from central access (Strong Recommendation against) 11
  5. Monitor for beta-blocker interference with exercise therapy – this is a critical treatment component that can be undermined by beta-blocker side effects 1

The evidence base remains limited with no FDA-approved medications specifically for POTS 45. Most studies are small, underpowered, and lack long-term follow-up 15. However, midodrine has the strongest evidence base and guideline support as an alternative to metoprolol.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.